Glumetza® for Type 2 Diabetes

PLEASE CLICK ON THE LINK BELOW TO FIND INFORMATION ABOUT GLUMETZA®.

Full prescribing and safety information can be found at www.glumetzaxr.com.

Commercialization and Partnering

U.S. commercialization of Glumetza commenced in September 2006.
Glumetza is marketed by Santarus, Inc. in the United States.

Outside of the United States, Glumetza is marketed in Canada by Biovail Corporation (NYSE:BVF)(TSX:BVF). Depomed is actively seeking commercialization partners for European territories.

If you have any questions regarding our marketing products, please call 1.866.458.6389.